| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-127 |
Sentence |
denotes |
Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1. |
| T1 |
0-127 |
Sentence |
denotes |
Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1. |
| TextSentencer_T2 |
128-206 |
Sentence |
denotes |
Increasing evidence suggests that FOXO1 possesses a tumor suppressor function. |
| T2 |
128-206 |
Sentence |
denotes |
Increasing evidence suggests that FOXO1 possesses a tumor suppressor function. |
| TextSentencer_T3 |
207-351 |
Sentence |
denotes |
Inactivation of FOXO1 has been documented in many types of human cancer, and restoring the activity of FOXO1 holds promise for cancer treatment. |
| T3 |
207-351 |
Sentence |
denotes |
Inactivation of FOXO1 has been documented in many types of human cancer, and restoring the activity of FOXO1 holds promise for cancer treatment. |
| TextSentencer_T4 |
352-558 |
Sentence |
denotes |
In this study, we identified a FOXO1-derived peptide termed FO1-6nls that inhibits cyclin-dependent kinases 1 and 2 (CDK1/2)-mediated phosphorylation of FOXO1 at the serine 249 residue in vitro and in vivo. |
| T4 |
352-558 |
Sentence |
denotes |
In this study, we identified a FOXO1-derived peptide termed FO1-6nls that inhibits cyclin-dependent kinases 1 and 2 (CDK1/2)-mediated phosphorylation of FOXO1 at the serine 249 residue in vitro and in vivo. |
| TextSentencer_T5 |
559-733 |
Sentence |
denotes |
Overexpression of FO1-6nls in prostate cancer (PCa) cells not only blocked CDK1-induced cytoplasmic localization of FOXO1 but also augmented FOXO1's transcriptional activity. |
| T5 |
559-733 |
Sentence |
denotes |
Overexpression of FO1-6nls in prostate cancer (PCa) cells not only blocked CDK1-induced cytoplasmic localization of FOXO1 but also augmented FOXO1's transcriptional activity. |
| TextSentencer_T6 |
734-796 |
Sentence |
denotes |
This effect of FO1-6nls requires its binding to CDK1 and CDK2. |
| T6 |
734-796 |
Sentence |
denotes |
This effect of FO1-6nls requires its binding to CDK1 and CDK2. |
| TextSentencer_T7 |
797-896 |
Sentence |
denotes |
Moreover, the ectopic expression of FO1-6nls inhibited the growth of PTEN-positive DU145 PCa cells. |
| T7 |
797-896 |
Sentence |
denotes |
Moreover, the ectopic expression of FO1-6nls inhibited the growth of PTEN-positive DU145 PCa cells. |
| TextSentencer_T8 |
897-975 |
Sentence |
denotes |
Importantly, the growth-inhibitory function of FO1-6nls is dependent on FOXO1. |
| T8 |
897-975 |
Sentence |
denotes |
Importantly, the growth-inhibitory function of FO1-6nls is dependent on FOXO1. |
| TextSentencer_T9 |
976-1094 |
Sentence |
denotes |
Finally, the ectopic expression of FO1-6nls overcame CDK1-mediated inhibition of FOXO1-induced apoptosis of PCa cells. |
| T9 |
976-1094 |
Sentence |
denotes |
Finally, the ectopic expression of FO1-6nls overcame CDK1-mediated inhibition of FOXO1-induced apoptosis of PCa cells. |
| TextSentencer_T10 |
1095-1353 |
Sentence |
denotes |
These results indicate that the FOXO1-derived peptide FO1-6nls can restore FOXO1's tumor suppressor function by specifically opposing CDK1/2-mediated phosphorylation and inhibition of FOXO1 and hence may have a therapeutic potential for the treatment of PCa. |
| T10 |
1095-1353 |
Sentence |
denotes |
These results indicate that the FOXO1-derived peptide FO1-6nls can restore FOXO1's tumor suppressor function by specifically opposing CDK1/2-mediated phosphorylation and inhibition of FOXO1 and hence may have a therapeutic potential for the treatment of PCa. |